Garnica-Cuellar, Juan Carlos http://orcid.org/0000-0002-4520-3659
Morales-Villegas, Enrique http://orcid.org/0000-0003-4107-3145
López-Forero, Carmen Alicia http://orcid.org/0000-0003-3054-0609
Monroy-Cruz, Bárbara
Pariti, Bhrugu
Deshwal, Swati
Sekharan, Manisha
Osorio-Hernández, Mariana http://orcid.org/0000-0001-9830-2725
García-Appendini, Ida Caterina http://orcid.org/0000-0002-0683-2292
Funding for this research was provided by:
Novo Nordisk Mexico (-)
Article History
Accepted: 3 April 2023
First Online: 15 July 2023
Declarations
:
: The present cost-effectiveness analysis was supported by funding from Novo Nordisk Mexico. The article processing charges and open access fee for this publication were funded by Novo Nordisk Mexico.
: Juan Carlos Garnica-Cuellara and Enrique Morales-Villegas, speakers on behalf of Novo Nordisk Mexico, have received consulting fees from Novo Nordisk Mexico in activities unrelated to this manuscript. However, they have not received any remuneration regarding the development of this manuscript. Enrique Morales-Villegas collaborated as principal investigator on DUAL VII, is speaker for Novo Nordisk Mexico and also received consulting fees from Novo Nordisk Mexico. Carmen Alicia Lopez-Forero and Bárbara Monroy-Cruz are employees of Novo Nordisk Mexico. Bhrugu Pariti, Swati Deshwal, and Manisha Sekharan are employees of Novo Nordisk A/S. Mariana Osorio-Hernández and Ida Caterina García-Appendini are employees of IQVIA Mexico, which received consulting fees from Novo Nordisk Mexico to support preparation of the analysis.
: As this study used data from secondary sources and did not involve direct interaction with human or animal subjects, it was exempt from review by Novo Nordisk’s ethics committee.
: This study involves information coming from published literature and contain no patient personal information. Therefore, patients’ consent is not needed.
: Not applicable
: The input data for this cost-effectiveness analysis was obtained by extracting relevant information directly from other clinical trials. Further details on the specific trials and data extracted can be found in the methods section of this publication.
: BM-C and CAL-F, conducted substantially to the design of this article. BM-C, BP, and SD conducted the economic analysis. BM-C and CAL-F conducted the collection data for the analysis tool, all authors participated in the writing sections of all the manuscript. All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this manuscript, take responsibility for the integrity of the work as a whole, and have given final approval for the version to be published.
: The model was performed in MS Excel<sup>®</sup>; however, this is not available for its consultation.
: This article is distributed under the terms of the Creative Commons Attribution-Non Commercial 4.0 International License (ExternalRef removed), which allows non-commercial use, distribution, and reproduction in any medium, provided appropriate credit is given to the original author(s).